Related Experiment Video
Updated: Jul 2, 2026
07:33
Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
Carcinoembryonic antigen as a vaccine target
Dongmei Wang1, Shayan Rayani, John L Marshall
1National Cancer Institute, 10 Center Drive, Building 10, Room 12 N226, Bethesda, MD 20892, USA. wangdong@mail.nih.gov
Expert Review of Vaccines
|September 5, 2008
Summary
This review explores vaccines targeting carcinoembryonic antigen (CEA), highlighting progress in harnessing the immune system for clinical benefit and immune response modulation.
Area of Science:
- Immunology
- Vaccinology
- Oncology
Background:
- The immune system's potential for therapeutic applications is increasingly recognized.
- Significant advancements have been made in understanding and manipulating immune responses.
- Carcinogenesis involves complex interactions with the immune system.
Purpose of the Study:
- To review vaccines designed to target carcinoembryonic antigen (CEA).
- To explore the clinical benefits and immune alterations associated with CEA-targeted vaccines.
- To provide an overview of current research in this specific area of cancer immunotherapy.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of vaccine strategies targeting CEA.
- Evaluation of immune response data and clinical outcomes.
Main Results:
- Evidence of clinical benefit in patients receiving CEA-targeted vaccines.
- Consistent and measurable alterations in the immune response observed.
- Various vaccine platforms are being investigated for CEA targeting.
Conclusions:
- CEA-targeted vaccines represent a promising avenue in cancer immunotherapy.
- Further research is warranted to optimize vaccine efficacy and patient selection.
- Harnessing the immune system through vaccination shows significant therapeutic potential.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...